{"data":{"ticker":"KNSA","name":"Kiniksa Pharmaceuticals International, plc","cik":"0001730430","quarterly":[{"frame":"CY2023Q2","end":"2023-06-30","revenue":71473000,"netIncome":14972000,"epsDiluted":0.21},{"frame":"CY2023Q3","end":"2023-09-30","revenue":67046000,"netIncome":-13855000,"epsDiluted":-0.2},{"frame":"CY2023Q4","end":"2023-12-31","revenue":83395000,"netIncome":null,"epsDiluted":null,"derived":true},{"frame":"CY2024Q1","end":"2024-03-31","revenue":79858000,"netIncome":-17704000,"epsDiluted":-0.25},{"frame":"CY2024Q2","end":"2024-06-30","revenue":108631000,"netIncome":-3908000,"epsDiluted":-0.06},{"frame":"CY2024Q3","end":"2024-09-30","revenue":112214000,"netIncome":-12693000,"epsDiluted":-0.18},{"frame":"CY2024Q4","end":"2024-12-31","revenue":122536000,"netIncome":null,"epsDiluted":null,"derived":true},{"frame":"CY2025Q1","end":"2025-03-31","revenue":137785000,"netIncome":8539000,"epsDiluted":0.11},{"frame":"CY2025Q2","end":"2025-06-30","revenue":156797000,"netIncome":17832000,"epsDiluted":0.23},{"frame":"CY2025Q3","end":"2025-09-30","revenue":180855000,"netIncome":18435000,"epsDiluted":0.23},{"frame":"CY2025Q4","end":"2025-12-31","revenue":202127000,"netIncome":null,"epsDiluted":null,"derived":true},{"frame":"CY2026Q1","end":"2026-03-31","revenue":214266000,"netIncome":22592000,"epsDiluted":0.27}],"annual":[{"frame":"CY2020","end":"2020-12-31","revenue":null,"netIncome":-161381000,"operatingCashFlow":-136532000,"capex":283000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","revenue":38544000,"netIncome":null,"operatingCashFlow":-126298000,"capex":415000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","revenue":220180000,"netIncome":null,"operatingCashFlow":5807000,"capex":105000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","revenue":270259000,"netIncome":null,"operatingCashFlow":13301000,"capex":130000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","revenue":423239000,"netIncome":null,"operatingCashFlow":25689000,"capex":277000,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","revenue":677564000,"netIncome":null,"operatingCashFlow":137985000,"capex":1568000,"buybacks":null,"dividends":null}],"latest":{"end":"2026-03-31","cash":189952000,"debt":null,"equity":605687000,"assets":825280000,"sharesOutstanding":null,"sharesDate":null,"form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD"},"updatedAt":"2026-09-14T18:12:59.121Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}